IPO registrations (S-1, F-1) · Registrants
Echo Therapeutics, Inc.
- SEC CIK
- 1031927 · filings on EDGAR ↗
- Former names
- SONTRA MEDICAL CORP (2002–2007); CHOICETEL COMMUNICATIONS INC/MN/ (2002–2002); CHOICETEL COMMUNICATIONS INC /MN/ (1997–2002)
- Registration
- Form S-1, first filed 2013-12-02; 1 initial registration, 0 amendments
- Outcome
- Withdrawal requested 2013-12-17
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 1809 HUDSON PARK, Edgewater, NJ 07020
- EIN
- 41-1649949
- EDGAR entity type
- operating
- Insiders and CEO pay
- Echo Therapeutics, Inc. on the corporate pages
Offering terms
- Shares offered
- 3,225,806
- Listing
- Nasdaq under the symbol ECTE
- Lead underwriters
- Roth Capital Partners
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: ECHO THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Form D issuer: Echo Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: Echo Therapeutics, Inc. EXACT (CIK (EXACT))
- Person page: Elazer R Edelman Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 2
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-12-02 | S-1 | S-1 (registration) | Echo Therapeutics, Inc. | 0001415889-13-002481 ↗ |
| 2013-12-17 | RW | RW (withdrawal request) | Echo Therapeutics, Inc. | 0001415889-13-002588 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-02 | S-1 | registration statement | 3,225,806 | - | Nasdaq ECTE | 1 | primary document; shares headline, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| DAVISON THOMAS W | Director,Officer | Acting President and CEO; President and CEO | 5 | 2006–2007 | |
| Marston Barry | Officer | VP of Sales & Marketing | 4 | 2006–2007 | |
| MORAN SEAN | Officer | Chief Financial Officer | 2 | 2006 | |
| AMARAL JOSEPH | Director | 3 | 2006–2007 | ||
| KOHLER GARY S | Director | 3 | 2006–2007 | ||
| LANGER ROBERT | Director | 6 | 2006–2010 | ||
| PUORRO GERARD E | Director | 4 | 2006–2007 | ||
| SULLIVAN BRIAN F | Director | 2 | 2006 | ||
| WIGLEY MICHAEL | Director | 7 | 2006–2008 | ||
| Mitchell Harry | Officer | CFO and COO; CFO AND COO; CFO and Treasurer; Chief Operating Officer & CFO; Chief Operating Officer/ CFO; Interim CEO; Interim CEO and Acting CFO; Interim CEO and CFO; Interim CFO | 10 | 2006–2011 | |
| Witoshkin Walter W | Director | 5 | 2007–2010 | ||
| MOONEY PATRICK T | Director,Officer | CEO and President; CEO AND PRESIDENT; Chief Executive Officer | 9 | 2007–2012 | |
| Singh Shawn | Director; Director,Officer | President (interim); President (Interim) | 4 | 2007–2010 | |
| Cato Allen Easley | TenPercentOwner | 1 | 2007 | ||
| CATO HOLDING CO | TenPercentOwner | 1 | 2007 | ||
| ENRIGHT VINCENT D | Director | 13 | 2008–2014 | ||
| GRIECO WILLIAM | Director | 12 | 2011–2014 | ||
| SMITH JAMES FRANCIS | Director | 12 | 2011–2014 | ||
| SCHNITTKER CHRISTOPHER P. | Officer | CFO | 5 | 2011–2012 | |
| BURKE KIMBERLY A | Officer | General Counsel; GENERAL COUNSEL | 4 | 2011–2012 | |
| Doman Robert F | Director; Director,Officer | EXEC. CHAIRMAN AND INTERIM CEO | 8 | 2013 | |
| LANDESMAN URI | TenPercentOwner | 6 | 2013–2014 | ||
| Nordlicht Mark | TenPercentOwner | 7 | 2013–2015 | ||
| Platinum Long Term Growth VII, LLC | TenPercentOwner | 2 | 2013 | ||
| Platinum Management (NY) LLC | TenPercentOwner | 7 | 2013–2015 | ||
| Platinum-Montaur Life Sciences, LLC | TenPercentOwner | 7 | 2013–2015 | ||
| Platinum Partners Liquid Opportunity Master Fund L.P. | TenPercentOwner | 7 | 2013–2015 | ||
| Platinum Partners Value Arbitrage Fund, LP | TenPercentOwner | 7 | 2013–2015 | ||
| Platinum Liquid Opportunity Management (NY) LLC | TenPercentOwner | 6 | 2013–2015 | ||
| GOLDBERG MICHAEL M | Director | 6 | 2014–2017 | ||
| GOLDBERG SHEPARD M | Director | 6 | 2014–2017 | ||
| Bernhardt Charles Thomas III | Officer | Interim CFO | 1 | 2014 | |
| Hollander Scott Wayne | Director,Officer | President and CEO; PRESIDENT AND CEO | 3 | 2015–2016 | |
| SCHOENBART ALAN WAYNE | Director,Officer; Officer | CEO, CFO AND SECRETARY; CFO and Secretary; CFO AND SECRETARY; INTERIM CEO, CFO AND SECRETARY | 6 | 2015–2017 | |
| Edelman Elazer R | Director | 3 | 2016 | person page Fuzzy |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-02-08 | Echo Therapeutics, Inc. | Biotechnology | $6,000,000 | $1,787,000 | 15 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Echo Therapeutics, Inc. | NJ | Form D private offerings | CIK (EXACT) |
| SEC filer | Echo Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | ECHO THERAPEUTICS, INC. | EIN (EXACT) | ||
| Person page | Elazer R Edelman | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, NJ first:
- Medifirst Solutions, Inc. NJ
- electroCore, Inc. NJ
- Origin Life Sciences, Inc. NJ
- Medisun Precision Medicine Ltd. 1T
- Solta Medical Corp A8
- ULTHERA INC AZ
- CardieX Ltd C3
- BeneChill, Inc. ca
- ENDOCARE INC CA
- IMAGYN MEDICAL INC CA
In other datasets, the same topic (Technology) in NJ:
- Form D issuer: A2Zlogix, Inc. (Form D private offerings)
- Lobbying client: 1KOSMOS INC (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology